OWENS & MINOR INC (OMI) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:OMI - US6907321029 - Common Stock
2.76 USD
-0.01 (-0.36%)
2.76 USD
0 (0%)
Overall OMI gets a fundamental rating of 3 out of 10. We evaluated OMI against 101 industry peers in the Health Care Providers & Services industry. While OMI is still in line with the averages on profitability rating, there are concerns on its financial health. OMI has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
OMI had positive earnings in the past year.
OMI had a negative operating cash flow in the past year.
In multiple years OMI reported negative net income over the last 5 years.
Each year in the past 5 years OMI had a positive operating cash flow.
1.2 Ratios
OMI's Return On Assets of -33.21% is on the low side compared to the rest of the industry. OMI is outperformed by 87.13% of its industry peers.
With an excellent Return On Invested Capital value of 10.36%, OMI belongs to the best of the industry, outperforming 81.19% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for OMI is below the industry average of 9.58%.
The last Return On Invested Capital (10.36%) for OMI is above the 3 year average (6.37%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -33.21% | ||
| ROE | N/A | ||
| ROIC | 10.36% |
ROA(3y)-2.73%
ROA(5y)-0.2%
ROE(3y)-22.09%
ROE(5y)-7.69%
ROIC(3y)6.37%
ROIC(5y)8.64%
1.3 Margins
OMI's Operating Margin of 3.07% is in line compared to the rest of the industry. OMI outperforms 56.44% of its industry peers.
OMI's Operating Margin has improved in the last couple of years.
The Gross Margin of OMI (26.13%) is comparable to the rest of the industry.
OMI's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.07% | ||
| PM (TTM) | N/A | ||
| GM | 26.13% |
OM growth 3Y-17.34%
OM growth 5Y15.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.28%
GM growth 5Y11.1%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), OMI is creating some value.
Compared to 1 year ago, OMI has more shares outstanding
The number of shares outstanding for OMI has been increased compared to 5 years ago.
Compared to 1 year ago, OMI has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.41, we must say that OMI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of OMI (1.41) is worse than 67.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.41 |
ROIC/WACC1.56
WACC6.63%
2.3 Liquidity
OMI has a Current Ratio of 0.86. This is a bad value and indicates that OMI is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of OMI (0.86) is worse than 79.21% of its industry peers.
A Quick Ratio of 0.84 indicates that OMI may have some problems paying its short term obligations.
The Quick ratio of OMI (0.84) is worse than 75.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.86 | ||
| Quick Ratio | 0.84 |
3. Growth
3.1 Past
The earnings per share for OMI have decreased strongly by -22.29% in the last year.
The Earnings Per Share has been growing by 22.10% on average over the past years. This is a very strong growth
The Revenue for OMI has decreased by -37.09% in the past year. This is quite bad
OMI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.04% yearly.
EPS 1Y (TTM)-22.29%
EPS 3Y-28.62%
EPS 5Y22.1%
EPS Q2Q%-40.48%
Revenue 1Y (TTM)-37.09%
Revenue growth 3Y3.03%
Revenue growth 5Y3.04%
Sales Q2Q%-74.37%
3.2 Future
Based on estimates for the next years, OMI will show a decrease in Earnings Per Share. The EPS will decrease by -1.16% on average per year.
OMI is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -26.97% yearly.
EPS Next Y-31.24%
EPS Next 2Y-19.68%
EPS Next 3Y-8.45%
EPS Next 5Y-1.16%
Revenue Next Year-74.09%
Revenue Next 2Y-50.65%
Revenue Next 3Y-36.4%
Revenue Next 5Y-26.97%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 2.14 indicates a rather cheap valuation of OMI.
OMI's Price/Earnings ratio is rather cheap when compared to the industry. OMI is cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.84, OMI is valued rather cheaply.
A Price/Forward Earnings ratio of 2.81 indicates a rather cheap valuation of OMI.
Based on the Price/Forward Earnings ratio, OMI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
OMI's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 2.14 | ||
| Fwd PE | 2.81 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, OMI is valued cheaper than 94.06% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 5.04 |
4.3 Compensation for Growth
OMI's earnings are expected to decrease with -8.45% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.1
EPS Next 2Y-19.68%
EPS Next 3Y-8.45%
5. Dividend
5.1 Amount
No dividends for OMI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
2.76
-0.01 (-0.36%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners96.53%
Inst Owner Change-0.77%
Ins Owners3.54%
Ins Owner Change-0.91%
Market Cap213.49M
Revenue(TTM)6.71B
Net Income(TTM)-1.34B
Analysts50
Price Target5.75 (108.33%)
Short Float %13.47%
Short Ratio5
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.21%
Min EPS beat(2)-6.28%
Max EPS beat(2)6.69%
EPS beat(4)3
Avg EPS beat(4)5.48%
Min EPS beat(4)-6.28%
Max EPS beat(4)16.66%
EPS beat(8)7
Avg EPS beat(8)4.92%
EPS beat(12)10
Avg EPS beat(12)14.96%
EPS beat(16)13
Avg EPS beat(16)13.17%
Revenue beat(2)0
Avg Revenue beat(2)-57.22%
Min Revenue beat(2)-75.28%
Max Revenue beat(2)-39.15%
Revenue beat(4)0
Avg Revenue beat(4)-29.29%
Min Revenue beat(4)-75.28%
Max Revenue beat(4)-0.59%
Revenue beat(8)1
Avg Revenue beat(8)-14.88%
Revenue beat(12)4
Avg Revenue beat(12)-9.25%
Revenue beat(16)7
Avg Revenue beat(16)-6.69%
PT rev (1m)-1.74%
PT rev (3m)-8.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.27%
EPS NY rev (1m)-0.19%
EPS NY rev (3m)1.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-37.5%
Revenue NY rev (1m)-0.85%
Revenue NY rev (3m)-0.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 2.14 | ||
| Fwd PE | 2.81 | ||
| P/S | 0.03 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.04 |
EPS(TTM)1.29
EY46.74%
EPS(NY)0.98
Fwd EY35.53%
FCF(TTM)-4.69
FCFYN/A
OCF(TTM)-1.28
OCFYN/A
SpS86.71
BVpS-5.55
TBVpS-23.57
PEG (NY)N/A
PEG (5Y)0.1
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -33.21% | ||
| ROE | N/A | ||
| ROCE | 13.12% | ||
| ROIC | 10.36% | ||
| ROICexc | 10.59% | ||
| ROICexgc | 113.35% | ||
| OM | 3.07% | ||
| PM (TTM) | N/A | ||
| GM | 26.13% | ||
| FCFM | N/A |
ROA(3y)-2.73%
ROA(5y)-0.2%
ROE(3y)-22.09%
ROE(5y)-7.69%
ROIC(3y)6.37%
ROIC(5y)8.64%
ROICexc(3y)6.65%
ROICexc(5y)8.97%
ROICexgc(3y)17.92%
ROICexgc(5y)17.9%
ROCE(3y)8.06%
ROCE(5y)10.94%
ROICexgc growth 3Y-4.88%
ROICexgc growth 5Y26.45%
ROICexc growth 3Y-21.55%
ROICexc growth 5Y13.72%
OM growth 3Y-17.34%
OM growth 5Y15.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.28%
GM growth 5Y11.1%
F-Score2
Asset Turnover1.66
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.03 | ||
| Cap/Depr | 105.46% | ||
| Cap/Sales | 3.93% | ||
| Interest Coverage | 1.54 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.86 | ||
| Quick Ratio | 0.84 | ||
| Altman-Z | 1.41 |
F-Score2
WACC6.63%
ROIC/WACC1.56
Cap/Depr(3y)77.12%
Cap/Depr(5y)69.93%
Cap/Sales(3y)1.94%
Cap/Sales(5y)1.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.29%
EPS 3Y-28.62%
EPS 5Y22.1%
EPS Q2Q%-40.48%
EPS Next Y-31.24%
EPS Next 2Y-19.68%
EPS Next 3Y-8.45%
EPS Next 5Y-1.16%
Revenue 1Y (TTM)-37.09%
Revenue growth 3Y3.03%
Revenue growth 5Y3.04%
Sales Q2Q%-74.37%
Revenue Next Year-74.09%
Revenue Next 2Y-50.65%
Revenue Next 3Y-36.4%
Revenue Next 5Y-26.97%
EBIT growth 1Y-30.13%
EBIT growth 3Y-14.84%
EBIT growth 5Y19.2%
EBIT Next Year23.37%
EBIT Next 3Y7.47%
EBIT Next 5YN/A
FCF growth 1Y-170.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-113.82%
OCF growth 3Y9.15%
OCF growth 5Y-0.56%
OWENS & MINOR INC / OMI FAQ
Can you provide the ChartMill fundamental rating for OWENS & MINOR INC?
ChartMill assigns a fundamental rating of 3 / 10 to OMI.
What is the valuation status for OMI stock?
ChartMill assigns a valuation rating of 6 / 10 to OWENS & MINOR INC (OMI). This can be considered as Fairly Valued.
What is the profitability of OMI stock?
OWENS & MINOR INC (OMI) has a profitability rating of 4 / 10.
What is the valuation of OWENS & MINOR INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for OWENS & MINOR INC (OMI) is 2.14 and the Price/Book (PB) ratio is -0.5.
What is the financial health of OWENS & MINOR INC (OMI) stock?
The financial health rating of OWENS & MINOR INC (OMI) is 1 / 10.